{"id":19721,"date":"2024-11-27T17:23:42","date_gmt":"2024-11-27T22:23:42","guid":{"rendered":"https:\/\/www.progeriaresearch.org\/?page_id=19721"},"modified":"2024-12-02T12:37:36","modified_gmt":"2024-12-02T17:37:36","slug":"progerinin_trial","status":"publish","type":"page","link":"https:\/\/www.progeriaresearch.org\/de\/progerinin_trial\/","title":{"rendered":"Jetzt anmelden: Neue Informationen zu klinischen Studien"},"content":{"rendered":"

[et_pb_section fb_built=”1″ fullwidth=”on” disabled_on=”off|off|off” _builder_version=”4.16″ border_width_bottom=”55px” border_color_bottom=”#29327a” locked=”off” collapsed=”off” global_colors_info=”{}”][et_pb_fullwidth_header _builder_version=”4.27.2″ title_font=”||||||||” title_font_size=”55″ background_color=”#29327a” background_image=”https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2023\/06\/header-Mio-Map-1-Dec-2017.jpg” background_position=”center_left” custom_padding=”7vw||7vw||true|” custom_padding_tablet=”” custom_padding_phone=”|56px||” custom_padding_last_edited=”on|desktop” title_font_size_tablet=”45px” title_font_size_phone=”40px” title_font_size_last_edited=”on|phone” z_index_tablet=”500″ custom_css_main_element=”background-position: center 18% !important;” global_colors_info=”{}”]<\/p>\n

<\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/h1>\n

Jetzt anmelden: <\/i><\/b><\/span><\/h1>\n

Neue Informationen zu klinischen Studien<\/i><\/b><\/span><\/h1>\n

[\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=”1″ use_custom_gutter=”on” gutter_width=”1″ specialty=”on” padding_left_1=”35px” padding_left_2=”35px” padding_2_tablet=”|||0px” padding_2_phone=”|||0px” padding_2_last_edited=”on|desktop” module_class_1=”sidebar-secondary-nav” module_class=”handprint-bg” _builder_version=”4.27.2″ background_image=”https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/04\/blue-handprint-only.png” parallax=”on” parallax_method=”off” inner_width=”100%” inner_max_width=”100%” custom_padding=”0|0px|54px|0px|false|false” z_index_tablet=”500″ border_width_top=”10px” border_color_top=”#8fd2ed” use_custom_width=”on” width_unit=”off” custom_width_percent=”100%” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_sidebar area=”et_pb_widget_area_1″ disabled_on=”on|on|off” admin_label=”Science Sidebar” module_class=”subpage-sidebars” _builder_version=”4.16″ animation_style=”fade” z_index_tablet=”500″ header_text_shadow_horizontal_length_tablet=”0px” header_text_shadow_vertical_length_tablet=”0px” header_text_shadow_blur_strength_tablet=”1px” body_text_shadow_horizontal_length_tablet=”0px” body_text_shadow_vertical_length_tablet=”0px” body_text_shadow_blur_strength_tablet=”1px” border_width_right=”5px” border_width_right_tablet=”5px” border_width_right_phone=”5px” box_shadow_horizontal_tablet=”0px” box_shadow_vertical_tablet=”0px” box_shadow_blur_tablet=”40px” box_shadow_spread_tablet=”0px” text_shadow_horizontal_length_tablet=”0px” text_shadow_vertical_length_tablet=”0px” text_shadow_blur_strength_tablet=”1px” locked=”off” global_colors_info=”{}”]
\n[\/et_pb_sidebar][\/et_pb_column][et_pb_column type=”3_4″ specialty_columns=”3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_row_inner custom_padding_last_edited=”on|phone” disabled_on=”on|on|” _builder_version=”4.16″ custom_padding=”39.4375px|35px|0px||false|false” custom_padding_tablet=”|35px||35px||true” custom_padding_phone=”” animation_direction=”top” z_index_tablet=”500″ global_colors_info=”{}”][et_pb_column_inner saved_specialty_column_type=”3_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text admin_label=”New Clinical Trial Information For Families and Their Physicians ” _builder_version=”4.27.2″ text_font_size=”18px” background_size=”initial” background_position=”top_left” background_repeat=”repeat” custom_margin=”||28px|||” hover_enabled=”0″ z_index_tablet=”500″ box_shadow_horizontal_tablet=”0px” box_shadow_vertical_tablet=”0px” box_shadow_blur_tablet=”40px” box_shadow_spread_tablet=”0px” global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

2. Dezember 2024 Beitrag:<\/em><\/strong><\/h4>\n

Neue Informationen zu klinischen Studien f\u00fcr Familien und ihre \u00c4rzte<\/em><\/strong><\/h4>\n

<\/strong><\/em><\/h4>\n

Die Anmeldung zur neuen klinischen Progerinin-Studie hat begonnen<\/strong><\/em><\/h4>\n

Die Anmeldung f\u00fcr die Progerininstudie ist jetzt ge\u00f6ffnet! Der Titel dieser Forschungsstudie lautet: Eine randomisierte, offene Phase-2a-Studie zur Bestimmung der optimalen Dosis und Bewertung der Sicherheit, Vertr\u00e4glichkeit und Pharmakokinetik von Progerinin bei Patienten mit Hutchinson-Gilford-Progerie-Syndrom (HGPS). Der Studienort ist das Boston Children's Hospital (BCH). Der Studiensponsor ist das in Korea ans\u00e4ssige Unternehmen PRG Science & Technology (PRG S&T). PRF arbeitet bei dieser Studie mit BCH und PRG S&T zusammen. Im Rahmen der Zusammenarbeit wird PRF die An- und Abreise zum Studienort in Boston sowie die Unterbringung w\u00e4hrend des Aufenthalts in Boston organisieren. Informationen zur Studie werden auch auf der Website ver\u00f6ffentlicht. clinicaltrials.gov<\/a><\/p>\n

[\/et_pb_text][et_pb_text admin_label=”Information For Patients with Progeria and their Doctors” _builder_version=”4.27.2″ text_text_color=”#000000″ text_font_size=”18px” background_size=”initial” background_position=”top_left” background_repeat=”repeat” custom_margin=”||19px|||” z_index_tablet=”500″ box_shadow_horizontal_tablet=”0px” box_shadow_vertical_tablet=”0px” box_shadow_blur_tablet=”40px” box_shadow_spread_tablet=”0px” global_colors_info=”{}”]<\/p>\n

Informationen f\u00fcr Patienten mit Progerie und ihre \u00c4rzte<\/em><\/strong><\/h5>\n